Search This Blog

Monday, March 2, 2020

BridgeBio Pharma EPS beats by $0.09

BridgeBio Pharma (NASDAQ:BBIO): Q4 GAAP EPS of -$0.62 beats by $0.09.
Revenue of $13.82M
Press Release
https://seekingalpha.com/news/3547398-bridgebio-pharma-eps-beats-0_09
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)